This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mueller, B. U. Search for Related Content PubMed PubMed Citation Articles by Mueller, B. U.

Cancers in Children Infected With the Human Immunodeficiency Virus

Harvard Medical School, Hunnewell Children's Hospital, Boston, Massachusetts, USA

Correspondence: Brigitta U. Mueller, M.D., Children's Hospital, Harvard Medical School, Hunnewell 320; HU-215 Children's Hospital, 300 Longwood Avenue, Boston, Massachusetts 02115, USA. Telephone: 617-355-8733; Fax: 617-738-7066; e-mail: mueller_b{at}a1.tch.harvard.edu

The AIDS epidemic continues unabated in Africa, Asia, and South America, and since patients survive longer, the number of chronically immunocompromised individuals is increasing in Europe and the United States. The number of children with HIV infection who will ultimately develop a malignancy is not known. Currently, tumors represent about 2% of the AIDS-defining events in children in the United States, but the incidence might be different in developing countries. The most common tumors in HIV-infected children are non-Hodgkin's lymphoma, smooth muscle tumors (leiomyosarcomas), and Kaposi's sarcoma (only in Africa). This article provides an overview of epidemiology and clinical and pathological presentations, as well as preliminary data regarding treatment options in children with HIV-associated malignancies.

Key Words. Human immunodeficiency virus • Epidemiology • Lymphoproliferative disorder • Non-Hodgkin's lymphoma • Leiomyosarcoma • Kaposi's sarcoma • Child

This article has been cited by other articles:

				K. C.M. Straathof, C. M. Bollard, C. M. Rooney, and H. E. Heslop Immunotherapy for Epstein-Barr Virus-Associated Cancers in Children Oncologist, February 1, 2003; 8(1): 83 - 98. [Abstract] [Full Text] [PDF]